Literature DB >> 8456429

Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis.

T W Wakefield1, L J Greenfield, M W Rolfe, A DeLucia, R M Strieter, G D Abrams, S L Kunkel, C T Esmon, S K Wrobleski, A M Kadell.   

Abstract

Theoretic and in vitro evidence suggests that thrombosis and inflammation are interrelated. The purpose of the present study was to define the relationship between inflammation and deep venous thrombosis (DVT) in an in vivo model. Initiation of DVT was accomplished by administration of antibody to protein C (HPC4, 2 mg/kg) and tumor necrosis factor (TNF, 150 micrograms/kg); stasis; and subtle venous catheter injury. Thrombosis was assessed by thrombin-antithrombin assay (TAT), 125I-fibrinogen scanning (scan) over both the proximal and distal iliac veins, and ascending venography. Cytokines TNF, interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1), and interleukin-8 (IL-8) were measured along with differential white blood cell counts, platelet counts, fibrinogen (FIB), and erythrocyte sedimentation rates (ESR). Baboon pairs were sacrificed on day 3 (T + 3d), T + 6d, and T + 9d and veins removed. All animals developed inferior vena cava and left iliofemoral DVT by venography; no right DVT was found. TAT was elevated by T + 1hr and peaked at T + 3hrs. Left iliofemoral DVT was found at T + 1hr by scan and reached a 20% uptake difference between the affected left and nonaffected right side at T + 3hrs. TNF peaked at T + 1hr; MCP-1 peaked at T + 6hrs; IL-8 and IL-6 peaked on T + 2d; all cytokines declined to baseline. TNF and TAT elevations were found to correlate with all cytokines; elevations in IL-8 were correlated with elevations in MCP-1 and IL-6 (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456429

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

Review 1.  Statins, inflammation and deep vein thrombosis: a systematic review.

Authors:  April L Rodriguez; Brandon M Wojcik; Shirley K Wrobleski; Daniel D Myers; Thomas W Wakefield; Jose A Diaz
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

2.  The characterization of mice with a targeted combined deficiency of protein c and factor XI.

Authors:  J C Chan; J G Ganopolsky; I Cornelissen; M A Suckow; M J Sandoval-Cooper; E C Brown; F Noria; D Gailani; E D Rosen; V A Ploplis; F J Castellino
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Deep vein thrombosis and systemic inflammatory response: a pilot trial.

Authors:  Markus Reiter; Robert A Bucek; Nihat Koca; Albert Dirisamer; Erich Minar
Journal:  Wien Klin Wochenschr       Date:  2003-02-28       Impact factor: 1.704

Review 4.  Statins as a preventative therapy for venous thromboembolism.

Authors:  Alex Wallace; Hassan Albadawi; Peter Hoang; Andrew Fleck; Sailendra Naidu; Grace Knuttinen; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

5.  Experimental study on the preventive mechanism of salviae miltiorrhizae against atherosclerosis in rabbits models.

Authors:  Shusheng Li; Lei Wan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 6.  Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis.

Authors:  Ayesha Zia; Joy Russell; Ravi Sarode; Surendranath R Veeram; Shellie Josephs; Kendra Malone; Song Zhang; Janna Journeycake
Journal:  Thromb Res       Date:  2017-10-07       Impact factor: 3.944

7.  Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor.

Authors:  I Ikonomidis; F Andreotti; P Nihoyannopoulos
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

8.  Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.

Authors:  G M Thomas; A Brill; S Mezouar; L Crescence; M Gallant; C Dubois; D D Wagner
Journal:  J Thromb Haemost       Date:  2015-06-08       Impact factor: 5.824

9.  Elevated plasma levels of interleukin 8 in patients with acute anterior ischaemic optic neuropathy.

Authors:  N Goldenberg-Cohen; M Kramer; I Bahar; Y Monselise; D Weinberger
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

10.  Cu(2+)-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy.

Authors:  Jianhui Wu; Yuji Wang; Yaonan Wang; Ming Zhao; Xiaoyi Zhang; Lin Gui; Shurui Zhao; Haimei Zhu; Jinghua Zhao; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2015-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.